National University Corporation - Notice on the use of single tendering procedures①SPINRAZA Intrathecal injection 12mg 1 vial, 2,②Kymriah Suspension for Intravenous Infusion 1 set, 5,③ZOLGENSMA Intravenous Infusion 1 set, 1,④UPLIZNA for Intravenous Infusion 3 vials, 5,⑤YESCARTA Intravenous Drip Infusion 1 bag, 7,⑥Breyanzi Suspension for Intravenous Infusion 1 Set, 2,⑦Abecma In...

This procurement is covered by the WTO Agreement on Government Procurement, Japan-EU Economic Partnership Agreement or Japan-UK Comprehensive Economic Partnership Agreement.

Japanese

Publishing date Mar 06, 2025
Type of notice Notice on the use of single tendering procedures
Procurement entity National University Corporation - Tokyo
Classification
0004 Medical & Pharmaceutical Products
Summay of notice ⑴ Classification of the products to be procured : 4
⑵ Nature and quantity of the products to be purchased :
① SPINRAZA Intrathecal injection 12mg 1 vial, 2
② Kymriah Suspension for Intravenous Infusion 1 set, 5
③ ZOLGENSMA Intravenous Infusion 1 set, 1
④ UPLIZNA for Intravenous Infusion 3 vials, 5
⑤ YESCARTA Intravenous Drip Infusion 1 bag, 7
⑥ Breyanzi Suspension for Intravenous Infusion 1 Set, 2
⑦ Abecma Intravenous Infusion 1 Bag,2
⑶ Expected date of the contract award : ①, ②, ③, ④, ⑤, ⑥, ⑦ 27 March, 2025
⑷ Reasons for the use single tendering procedures as provided for in the Agreement on Government Procurement : ①, ②, ③, ④, ⑤, ⑥, ⑦ b "Protection of Exclusive Rights"
⑸ Contact point for the notice : Terumasa Dan, Hospital Administration Division, Institute of Science Tokyo Hospital, 1-5-45 Yushima Bunkyo-ku Tokyo 113-8519 Japan, TEL 03-5803-5109